- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06504654
Interoception and Eating Behaviors in Children (I-EAT)
Study Overview
Status
Conditions
Detailed Description
The overall goal of this project is to examine if interoception (the process by which internal bodily states, like hunger and fullness, are sensed, integrated, interpreted, and regulated) is associated with BMI and obesity-related eating behaviors in children age 7-10 years. The specific aims are:
Aim 1: Determine associations between interoception and non-homeostatic eating H1: Multi-systems measures of interoceptive awareness (e.g., heartbeat perception, gastric interoception, self-reported interoceptive awareness) will be inversely associated with intake (kcal) in the eating in the absence of hunger (EAH) task
Aim 2: Assess salivary ghrelin and leptin as interoceptive signals of hunger/satiety H1: Children with greater postprandial suppression of ghrelin will eat less in the EAH task H2: Children with greater postprandial suppression of ghrelin will have better interoceptive awareness H3: Children with higher leptin will exhibit less sensitivity to changes in ghrelin
Aim 3 (Exploratory): Identify interoceptive phenotypes that may predict obesity risk Using k-means cluster analysis, we aim to identify subgroups of individuals who exhibit different combinations of interoceptive variables. We will then examine differences in eating behavior and weight between clusters.
Participants will attend two study visits at the Clinical Research Center at Penn State University Park campus. At the first visit, children will have their height, weight, and body composition measured, complete measures of interoception, and complete surveys/interview. Parents will complete a survey. At the second visit, children will eat a meal, taste snacks, provide saliva samples, and play cognitive games on a tablet.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Pennsylvania State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Child must be 7-10 years of age
- Participating parent must be at least 18 years of age, but there is no upper age limit
- Able to understand and answer questions in English
Exclusion Criteria (all applicable to child only):
- BMI for age <5th percentile
- Monogenic obesity condition (e.g., Prader Willi syndrome)
- Autism/autism spectrum disorder
- Developmental delay
- Eating disorder
- Diabetes
- Heart condition
- Taking medications impacting appetite (e.g., stimulants, weight control medications)
- Any other condition significantly impacting growth, eating behavior, or cardiac function
- Allergy or dietary restriction to study foods
- Severe/untreated oral/dental health problems
- Orthodontic procedure or adjustment of braces within the past omonth
- Oral surgery or major oral/dental procedure within past month
- Had an x-ray within the past month
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kcal consumed in the Eating in the Absence of Hunger protocol
Time Frame: Visit 2 (1-3 weeks after enrollment at Visit 1)
|
Children will be provide with an array of snacks following a meal and will have 10 minutes to consume any snacks that they would like.
Intake will be measured by pre- and post-weighing snacks
|
Visit 2 (1-3 weeks after enrollment at Visit 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pattern of salivary ghrelin in response to a meal
Time Frame: Visit 2 (1-3 weeks after enrollment at Visit 1)
|
Children will provide saliva samples at fasting, +30 minutes, +60 minutes, and +90 minutes from start of a meal, which will be analyzed for active ghrelin
|
Visit 2 (1-3 weeks after enrollment at Visit 1)
|
|
Pattern of salivary leptin in response to a meal
Time Frame: Visit 2 (1-3 weeks after enrollment at Visit 1)
|
Children will provide saliva samples at fasting, +30 minutes, +60 minutes, and +90 minutes from the start of a meal, which will be analyzed for leptin
|
Visit 2 (1-3 weeks after enrollment at Visit 1)
|
|
Heart beat counting accuracy
Time Frame: Visit 1 (Enrollment)
|
Participants will be fitted with a heart rate monitor and will be asked to count their heartbeat over several time intervals.
Reported counts will be compared to measured heart rate to determine percent accuracy
|
Visit 1 (Enrollment)
|
|
Gastric interoception
Time Frame: Visit 1 (Enrollment)
|
Children will be asked to drink plain water until their stomach feels 'just right', and then will be asked to drink further water until their stomach feels maximally full.
The amount of water consumed in each phase will be measured by changes in weight of the water bottle.
The ratio of the two volumes is a measure of gastric interoception that is not confounded by stomach capacity
|
Visit 1 (Enrollment)
|
|
Multidimensional Assessment of Interoceptive Awareness (MAIA)-youth version
Time Frame: Visit 1 (Enrollment)
|
Children will complete a questionnaire via interview to assess their perception of their interoceptive awareness
|
Visit 1 (Enrollment)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00024712
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Childhood
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece